Public Employees Retirement System of Ohio Buys 29,577 Shares of AngioDynamics, Inc. (NASDAQ:ANGO)

Public Employees Retirement System of Ohio increased its stake in shares of AngioDynamics, Inc. (NASDAQ:ANGO) by 88.4% during the 3rd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 63,039 shares of the medical instruments supplier’s stock after acquiring an additional 29,577 shares during the period. Public Employees Retirement System of Ohio owned about 0.16% of AngioDynamics worth $461,000 as of its most recent filing with the SEC.

Several other institutional investors and hedge funds have also bought and sold shares of the stock. Gladius Capital Management LP bought a new stake in AngioDynamics during the third quarter worth about $30,000. American Century Companies Inc. raised its stake in AngioDynamics by 46.3% in the third quarter. American Century Companies Inc. now owns 19,412 shares of the medical instruments supplier’s stock valued at $142,000 after buying an additional 6,142 shares during the period. Deutsche Bank AG raised its stake in AngioDynamics by 38.5% in the third quarter. Deutsche Bank AG now owns 18,083 shares of the medical instruments supplier’s stock valued at $132,000 after buying an additional 5,025 shares during the period. Diversified Trust Co bought a new stake in AngioDynamics in the third quarter valued at approximately $124,000. Finally, Jacobs Levy Equity Management Inc. raised its stake in AngioDynamics by 62.4% in the third quarter. Jacobs Levy Equity Management Inc. now owns 713,899 shares of the medical instruments supplier’s stock valued at $5,219,000 after buying an additional 274,210 shares during the period. Institutional investors own 89.43% of the company’s stock.

AngioDynamics Trading Up 5.6 %

AngioDynamics stock opened at $5.70 on Thursday. AngioDynamics, Inc. has a 12 month low of $5.26 and a 12 month high of $12.62. The stock’s 50 day moving average is $5.81 and its 200-day moving average is $6.55. The company has a market capitalization of $227.15 million, a price-to-earnings ratio of -16.29 and a beta of 0.66.

AngioDynamics (NASDAQ:ANGO) last posted its earnings results on Friday, January 5th. The medical instruments supplier reported ($0.05) EPS for the quarter, beating the consensus estimate of ($0.09) by $0.04. AngioDynamics had a negative return on equity of 1.78% and a negative net margin of 4.28%. The company had revenue of $79.07 million for the quarter, compared to the consensus estimate of $81.65 million. As a group, equities research analysts predict that AngioDynamics, Inc. will post -0.44 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

Several research firms have issued reports on ANGO. Raymond James dropped their price objective on AngioDynamics from $12.00 to $10.00 and set an “outperform” rating on the stock in a research note on Tuesday, January 9th. HC Wainwright dropped their price objective on AngioDynamics from $20.00 to $18.00 and set a “buy” rating on the stock in a research note on Monday, January 8th.

AngioDynamics Profile

AngioDynamics, Inc provides invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology in the United States and internationally. It offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium for treatment of peripheral arterial disease.